TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20

TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20

<p><strong>Objectives</strong></p> <p>About half of RA patients treated with TNFα inhibitors either do not respond or lose their initial therapeutic response over time. The clinical response is measured by reduction in DAS28, which primarily reflects inflammation. Howev...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Al-Bogami, M, Bystrom, J, Clanchy, F, Taher, TE, Mangat, P, Williams, RO, Jawad, AS, Mageed, RA
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Oxford University Press 2020

Gelijkaardige items

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
door: Bystrom, J, et al.
Gepubliceerd in: (2017)

TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
door: Bystrom, J, et al.
Gepubliceerd in: (2016)

Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
door: Clanchy, FIL, et al.
Gepubliceerd in: (2022)

TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
door: Clanchy, FIL, et al.
Gepubliceerd in: (2021)

Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance
door: Taylor, PC, et al.
Gepubliceerd in: (2024)

New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis
door: Emilie Hascoët, et al.
Gepubliceerd in: (2023-05-01)

Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions
door: H. Allard-Chamard, et al.
Gepubliceerd in: (2020-06-01)

Harnessing the Therapeutic Potential of Th17 Cells.
door: Bystrom, J, et al.
Gepubliceerd in: (2015)

Osteoclast differentiation in rheumatoid arthritis
door: Kazuhiro Yokota
Gepubliceerd in: (2024-01-01)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
door: Delphine Dénarié, et al.
Gepubliceerd in: (2017-01-01)

Functional and phenotypic heterogeneity of Th17 cells in health and disease
door: Bystrom, J, et al.
Gepubliceerd in: (2018)

Pathological Osteoclasts and Precursor Macrophages in Inflammatory Arthritis
door: Tetsuo Hasegawa, et al.
Gepubliceerd in: (2022-04-01)

Lymphocytes: precursor frequencies
door: Clanchy, F, et al.
Gepubliceerd in: (2017)

Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.
door: Marieke M J Herenius, et al.
Gepubliceerd in: (2013-01-01)

Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
door: Qing Niu, et al.
Gepubliceerd in: (2022-11-01)

Harnessing the Therapeutic Potential of Th17 Cells
door: Jonas Bystrom, et al.
Gepubliceerd in: (2015-01-01)

Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
door: Hirayama, T, et al.
Gepubliceerd in: (2002)

The role of osteoclast formation in the pathogenesis of osteoporosis in rheumatoid arthritis
door: Hirayama, T, et al.
Gepubliceerd in: (2001)

The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings
door: Naoki Iwamoto, et al.
Gepubliceerd in: (2022-09-01)

CD14+CD16− monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK
door: Jimeng Xue, et al.
Gepubliceerd in: (2020-09-01)

20th anniversary of TNF inhibitors in rheumatoid arthritis
door: Taylor, P
Gepubliceerd in: (2019)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
door: Feldmann, M, et al.
Gepubliceerd in: (2011)

Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.
door: Yu Xue, et al.
Gepubliceerd in: (2012-01-01)

Cellular mechanisms of osteoclast formation and bone resorption in rheumatoid arthritis
door: Danks, L, et al.
Gepubliceerd in: (2001)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
door: Maini, R, et al.
Gepubliceerd in: (1993)

Th17 Lymphocytes in Respiratory Syncytial Virus Infection
door: Rizgar A. Mageed, et al.
Gepubliceerd in: (2013-03-01)

Mir-342-3p regulates ostoclastogenesis in arthritis-associated osteoclast precursors
door: Claire Lozano, et al.
Gepubliceerd in: (2020-10-01)

Development of anti-TNF therapy for rheumatoid arthritis.
door: Feldmann, M
Gepubliceerd in: (2002)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
door: Maini, R, et al.
Gepubliceerd in: (1994)

Preventive CCL2/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2hi Osteoclast Progenitors to the Affected Bone
door: Darja Flegar, et al.
Gepubliceerd in: (2021-12-01)

The role of light in osteoclast formation and pathological bone resorption in rheumatoid arthritis
door: Athanasou, NA, et al.
Gepubliceerd in: (2017)

Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent.
door: Itonaga, I, et al.
Gepubliceerd in: (2000)

Osteoclast microRNA Profiling in Rheumatoid Arthritis to Capture the Erosive Factor
door: Nguyen Hoang Dong, et al.
Gepubliceerd in: (2023-08-01)

How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
door: Ulrike Steffen, et al.
Gepubliceerd in: (2019-07-01)

The number of CD14+osteoclast precursors in acute charcot patients is correlated to the serum levels of tnf-alpha
door: Mabilleau, G, et al.
Gepubliceerd in: (2009)

Regulation of TNF-Induced Osteoclast Differentiation
door: Zhenqiang Yao, et al.
Gepubliceerd in: (2021-12-01)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
door: E. A. Golikova, et al.
Gepubliceerd in: (2012-05-01)

Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
door: Elden Aake, et al.
Gepubliceerd in: (2011-02-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
door: Hisakata Yamada, et al.
Gepubliceerd in: (2020-04-01)

Reduced skeletal muscle independently predicts 1-year aggravated joint destruction in patients with rheumatoid arthritis
door: Jian-Zi Lin, et al.
Gepubliceerd in: (2020-08-01)